Akoya Biosciences, Inc.

As of the latest reporting, Akoya Biosciences, Inc. does not have specific carbon emissions data available. However, the company has made significant climate commitments aimed at reducing greenhouse gas emissions across its operations.

Akoya has set ambitious near-term targets to achieve a 50% reduction in scope 1, 2, and 3 in-use operational greenhouse gas emissions of owned and leased buildings by 2030, using 2023 as the base year. Additionally, the company aims to reduce scope 3 emissions from purchased goods and services and capital goods by 51.6% within the same timeframe. Furthermore, Akoya is committed to reducing absolute scope 3 emissions from various activities, including upstream transportation and waste management, by 42% by 2030.

In the long term, Akoya has pledged to reach net-zero greenhouse gas emissions across its entire value chain by 2050. This includes a target to reduce scope 1, 2, and 3 emissions by 95.4% per square metre by 2050, alongside a 97% reduction in scope 3 emissions from purchased goods and services and capital goods.

These commitments are part of Akoya's alignment with the Science Based Targets initiative (SBTi), ensuring that their targets are consistent with the reductions required to limit global warming to 1.5°C. The company is also committed to not installing any new fossil fuel equipment in its buildings from January 1, 2030.

Overall, while specific emissions data is currently unavailable, Akoya Biosciences, Inc. is actively working towards substantial reductions in greenhouse gas emissions through its comprehensive climate strategy.